For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Kai Pharmaceuticals, Inc.

USPTO Granted Patents = 19

% Expired Patents = 42.1

EPO Patents = 9

Forward Citations = 119

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Derek Maclean (11 out of 19 patents)

Qun Yin (8 out of 30 patents)

Felix D Karim (8 out of 11 patents)

4. Amos Baruch (6 out of 6 patents)

5. Kanad Das (6 out of 6 patents)

6. Paul A Wender (3 out of 42 patents)

7. Mike Tso-Ping Li (3 out of 6 patents)

8. Jonathan B Rothbard (3 out of 22 patents)

9. Lalitha V S Sista (3 out of 8 patents)

10. Thorsten A Kirschberg (3 out of 8 patents)

11. Gregory Bell (2 out of 2 patents)

12. P Leo McGrane (2 out of 7 patents)

13. Sarah Walter (1 out of 5 patents)

14. Leo P McGrane (1 out of 1 patent)

15. James E Tomlinson (12 patents)

19 patents: Sort by Forward Citations

1. 10280198 - Therapeutic agents for reducing parathyroid hormone levels (2019-05-07),

2. 10077438 - Modifications of peptide compositions to increase stability and delivery efficiency (2018-09-18),

3. 9701712 - Therapeutic agents for reducing parathyroid hormone levels (2017-07-11),

4. 9567370 - Therapeutic agents for reducing parathyroid hormone levels (2017-02-14),

5. 9278995 - Therapeutic agents for reducing parathyroid hormone levels (2016-03-08),

6. 9255124 - Modifications of peptide compositions to increase stability and delivery efficiency (2016-02-09),

7. 8999932 - Therapeutic agents for reducing parathyroid hormone levels (2015-04-07),

8. 8987200 - Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders (2015-03-24),

9. 8969299 - Therapeutic agents for regulating serum phosphorus (2015-03-03),

10. 8729010 - Compositions and methods for enhancing drug delivery across and into ocular tissues (2014-05-20),

11. 8623833 - Compositions and methods for enhancing drug delivery across and into epithelial tissues (2014-01-07),

12. 8524673 - Pharmaceutical formulation (2013-09-03),

13. 8492346 - Methods of use of epsilon inhibitor compounds for the attenuation of pain (2013-07-23),

14. 8377880 - Therapeutic agents for reducing parathyroid hormone levels (2013-02-19),

15. 8278264 - Compositions and methods for enhancing drug delivery across and into ocular tissues (2012-10-02),

KAI Pharmaceuticals, Inc. is a leading biopharmaceutical company focused on the research, development, and commercialization of innovative treatments for various medical conditions. With a strong emphasis on scientific excellence and patient-centric approach, KAI Pharmaceuticals aims to improve the lives of patients worldwide. The company's cutting-edge therapies are designed to address unmet medical needs and offer significant advancements in the field of healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

19 Patents

#67 in South San Francisco, CA

#4,091 in California

#17,095 in US

#32,551 in the World

South San Francisco, CA, United States of America

Kai Pharmaceuticals, Inc.

Forward Citations = 119

14 inventors:

Derek Maclean (11 out of 19 patents)

Qun Yin (8 out of 30 patents)

Felix D Karim (8 out of 11 patents)

4. Amos Baruch (6 out of 6 patents)

5. Kanad Das (6 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…